These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23829976)

  • 21. Women's views influence use.
    Barnett B
    Netw Res Triangle Park N C; 1995 Sep; 16(1):14-8. PubMed ID: 12290465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing repeat adolescent pregnancies with early adoption of the contraceptive implant.
    Stevens-Simon C; Kelly L; Singer D
    Fam Plann Perspect; 1999; 31(2):88-93. PubMed ID: 10224547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etonogestrel implant (Implanon) for contraception.
    Drug Ther Bull; 2001 Aug; 39(8):57-9. PubMed ID: 11526801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tolerance of the contraceptive implant by prescription context (postabortion or not): Prospective study on 127 consultants].
    Martin C; Tanguy M; Aspeele F; Fanello S
    J Gynecol Obstet Biol Reprod (Paris); 2010 Dec; 39(8):632-6. PubMed ID: 20970261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women's contraceptive choice following the use of Implanon NXT: Findings from a study in Durban, South Africa.
    Beesham I; Smit J; Bosman SL; Milford C; Panday M; Beksinska M
    Afr J Reprod Health; 2021 Feb; 25(1):41-48. PubMed ID: 34077109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acceptability of the etonogestrel-containing contraceptive implant (Implanon)].
    Sergent F; Clamageran C; Bastard AM; Verspyck E; Marpeau L
    J Gynecol Obstet Biol Reprod (Paris); 2004 Sep; 33(5):407-15. PubMed ID: 15480280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleeding related to etonogestrel subdermal implant in a US population.
    Casey PM; Long ME; Marnach ML; Bury JE
    Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Zealand women's experience during their first year of Jadelle® contraceptive implant.
    Roke C; Roberts H; Whitehead A
    J Prim Health Care; 2016 Mar; 8(1):13-9. PubMed ID: 27477370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. User perspectives on Implanon NXT in South Africa: A survey of 12 public-sector facilities.
    Pillay D; Chersich M; Morroni C; Pleaner M; Adeagbo OA; Naidoo N; Mullick S; Rees H
    S Afr Med J; 2017 Oct; 107(10):815-821. PubMed ID: 29397680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What matters most? The content and concordance of patients' and providers' information priorities for contraceptive decision making.
    Donnelly KZ; Foster TC; Thompson R
    Contraception; 2014 Sep; 90(3):280-7. PubMed ID: 24863169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levonorgestrel contraceptive implants in female patients 14 to 21 years old.
    Suman VJ; Van Winter JT; Evans MP; Simmons PS; Jacobsen SJ; Manolis AL
    Mayo Clin Proc; 1998 Jan; 73(1):10-6. PubMed ID: 9443673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contraceptive implant.
    Hohmann H; Creinin MD
    Clin Obstet Gynecol; 2007 Dec; 50(4):907-17. PubMed ID: 17982333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implant contraception in Singaporean women: one decade of experience in KK Women's and Children's Hospital.
    Kang W; Tan KH
    Singapore Med J; 2004 Oct; 45(10):482-6. PubMed ID: 15455169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing young women's decision making regarding hormonal contraceptives: a qualitative study.
    Cheung E; Free C
    Contraception; 2005 Jun; 71(6):426-31. PubMed ID: 15914131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What Goes In Must Come Out: A Mixed-Method Study of Access to Contraceptive Implant Removal Services in Ghana.
    Callahan R; Lebetkin E; Brennan C; Kuffour E; Boateng A; Tagoe S; Coolen A; Chen M; Aboagye P; Brunie A
    Glob Health Sci Pract; 2020 Jun; 8(2):220-238. PubMed ID: 32606092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of body mass index with removal of etonogestrel subdermal implant.
    Casey PM; Long ME; Marnach ML; Fleming-Harvey J; Drozdowicz LB; Weaver AL
    Contraception; 2013 Mar; 87(3):370-4. PubMed ID: 22959901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NORPLANT contraceptive implants advancing.
    Segal SJ
    Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement.
    Mark A; Sonalkar S; Borgatta L
    Contraception; 2013 Nov; 88(5):619-23. PubMed ID: 23790436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant.
    Croxatto HB
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():21-8. PubMed ID: 11246604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.